Pomegranate and Its Components, Punicalagin and Ellagic Acid, Promote Antidepressant, Antioxidant, and Free...

Area of Science:

• Neuropharmacology
• Natural Product Chemistry
• Oxidative Stress Research

Background:

• Previous studies indicated antidepressant-like effects of pomegranate extract.
• Oxidative stress and cellular dysfunction are implicated in mood disorders.
• Ovariectomy can induce physiological changes relevant to neurological function.

Purpose of the Study:

• To evaluate the antidepressant-like effects of pomegranate extract (AEPG) and its key compounds (punicalagin, ellagic acid).
• To assess the impact of AEPG, punicalagin, and ellagic acid on brain redox environment ex vivo.
• To investigate the radical scavenging capacities of these compounds.

Main Methods:

• Forced swimming test in rats to assess antidepressant-like behavior.
• Ex vivo assessment of reactive oxygen species (ROS) production, lipoperoxidation (LPX), and cellular function in rat brains exposed to pro-oxidants (FeSO4, ONOO-).
• Chemical combinatorial assays to determine radical scavenging capacities (IC50 values).

Main Results:

• AEPG, punicalagin, and ellagic acid significantly attenuated FeSO4-induced increases in ROS and LPX.
• AEPG and ellagic acid improved cellular function in pro-oxidant-exposed brain tissue.
• Punicalagin and ellagic acid demonstrated significant antidepressant-like effects at low doses, with AEPG showing superior radical scavenging capacity.

Conclusions:

• Aqueous extract of pomegranate (AEPG) and its active compounds, punicalagin and ellagic acid, possess antidepressant-like properties.
• These compounds exert antioxidant activity by attenuating oxidative damage and preventing cellular dysfunction in ovariectomized rat brains.
• Pomegranate-derived compounds represent a promising natural therapeutic strategy for mood disorders associated with oxidative stress.